MAPT and Lewy body dementia: Similarly, other studies comparing patterns of CSF biomarkers between patients with DLB and PDD showed that lower levels of Aβ1-42 (combined with higher tau levels) are associated with DLB rather than PDD and are seen particularly in patients with more rapidly progressive dementia79,80.